Dermata Therapeutics, Inc. — Form D/A

Dermata Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2025-02-04. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Other Technology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Brittany J BradrickDirectorSan Diego, CA
Mary J FisherDirectorSan Diego, CA
David J HaleDirectorSan Diego, CA
Steven J MentoDirectorSan Diego, CA
Gerald ProehlDirectorSAN DIEGO, CA
Andrew J SandlerDirectorSan Diego, CA
Kathleen J ScottDirectorSan Diego, CA
Wendell J WierengaDirectorSan Diego, CA
Maria J Bedoya Toro MuneraExecutive OfficerSan Diego, CA
Christopher J NardoExecutive OfficerSan Diego, CA
Gerald ProehlExecutive OfficerSAN DIEGO, CA
Kyri K Van HooseExecutive OfficerSan Diego, CA
Gerald T ProehlDirectorLa Jolla, CA
Gerald T ProehlExecutive OfficerLa Jolla, CA
Maria J. Bedoya Toro MuneraExecutive OfficerSAN DIEGO, CA
Mary J. FisherDirectorSAN DIEGO, CA
Kathleen J. ScottDirectorSAN DIEGO, CA
Steven J. MentoDirectorSAN DIEGO, CA
Wendell J. WierengaDirectorSAN DIEGO, CA
Andrew J. SandlerDirectorSAN DIEGO, CA
Kyri K. Van HooseExecutive OfficerSAN DIEGO, CA
David J. HaleDirectorSAN DIEGO, CA
Christopher J. NardoExecutive OfficerSAN DIEGO, CA
Brittany J. BradrickDirectorSAN DIEGO, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2026-01-07D$4.1M$4.1M
2025-01-28D$2.5M$2.5M
2024-09-27D$3.5M$3.5M
2023-06-12D

More